Skip to main content
Top
Published in: Surgical Endoscopy 11/2016

01-11-2016

Combination of etoricoxib and low-pressure pneumoperitoneum versus standard treatment for the management of pain after laparoscopic cholecystectomy: a randomized controlled trial

Authors: Wasana Ko-iam, Sahataya Paiboonworachat, Paisal Pongchairerks, Sunhawit Junrungsee, Trichak Sandhu

Published in: Surgical Endoscopy | Issue 11/2016

Login to get access

Abstract

Background and objectives

Postoperative pain is one of the significant problems in laparoscopic surgery, especially during the first 6–12 h. This randomized controlled trial aimed to investigate the effect of combined preemptive etoricoxib 120 mg and low-pressure pneumoperitoneum for the management of pain after laparoscopic cholecystectomy (LC).

Patients and methods

One hundred and twenty patients aged 18–75 with American Society of Anesthesiologists class I–II who were candidates for elective LC were recruited into the study. The patients were randomly divided into two groups, by ‘block of four’ randomization. The treatment group received preemptive etoricoxib 120 mg and intraabdominal pressure of 7 mmHg, and the control group received placebo and intraabdominal pressure of 14 mmHg. The postoperative pain score at rest was recorded utilizing a numeric rating scale at 1, 2, 6, 10, 14, 18, 22, and 24 h. Pain on movement/ambulation (cough) was also recorded at 6, 10, 14, 18, 22, and 24 h.

Results

There were no significant differences in the baseline characteristics of the two groups. The pain scores of the treatment versus control group of abdominal pain and incisional pain were significant on movement. Abdominal pain scores of the treatment group were decreased 0.98 when compared with the control group (p = 0.017), and incisional pain scores were also decreased 0.99 (p = 0.001). The incidences of postoperative shoulder/back pain were statistically significant: 41.8 % vs. 66.7 % in the treatment and control group, respectively (p = 0.009). The postoperative hospital stay in the treatment group and control group was: 1 day = 96.4 and 75.0 %, >1 day = 3.6 and 25.0 %, respectively (p = 0.001).

Conclusions

A combination of preemptive etoricoxib and low-pressure pneumoperitoneum had significant effects in decreasing overall pain and the incidence of shoulder/back pain after LC and also shortened the hospital stay.

Clinical trials registration number

TCTR20140213001.
Literature
1.
go back to reference Bisgaard T, Klarskov B, Rosenberg J, Kehlet H (2001) Characteristics and prediction of early pain after laparoscopic cholecystectomy. Pain 90:261–269CrossRefPubMed Bisgaard T, Klarskov B, Rosenberg J, Kehlet H (2001) Characteristics and prediction of early pain after laparoscopic cholecystectomy. Pain 90:261–269CrossRefPubMed
2.
go back to reference Kehlet H, Rung GW, Callesen T (1996) Postoperative opioid analgesia: time for a reconsideration? J Clin Anesth 8:441–445CrossRefPubMed Kehlet H, Rung GW, Callesen T (1996) Postoperative opioid analgesia: time for a reconsideration? J Clin Anesth 8:441–445CrossRefPubMed
3.
go back to reference Apfelbaum JL, Chen C, Mehta SS, Gan TJ (2003) Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg 97:534–540CrossRefPubMed Apfelbaum JL, Chen C, Mehta SS, Gan TJ (2003) Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg 97:534–540CrossRefPubMed
4.
go back to reference Sandhu T, Paiboonworachat S, Ko-iam W (2011) Effects of preemptive analgesia in laparoscopic cholecystectomy: a double-blind randomized controlled trial. Surg Endosc 25:23–27CrossRefPubMed Sandhu T, Paiboonworachat S, Ko-iam W (2011) Effects of preemptive analgesia in laparoscopic cholecystectomy: a double-blind randomized controlled trial. Surg Endosc 25:23–27CrossRefPubMed
5.
go back to reference Sandhu T, Yamada S, Ariyakachon V, Chakrabandhu T, Chongruksut W, Ko-iam W (2009) Low-pressure pneumoperitoneum versus standard pneumoperitoneum in laparoscopic cholecystectomy, a prospective randomized clinical trial. Surg Endosc 23:1044–1047CrossRefPubMed Sandhu T, Yamada S, Ariyakachon V, Chakrabandhu T, Chongruksut W, Ko-iam W (2009) Low-pressure pneumoperitoneum versus standard pneumoperitoneum in laparoscopic cholecystectomy, a prospective randomized clinical trial. Surg Endosc 23:1044–1047CrossRefPubMed
6.
go back to reference Dahl JB, Rosenberg J, Dirkes WE, Mogensen T, Kehlet H (1990) Prevention of postoperative pain by balanced analgesia. Br J Anaesth 64:518–520CrossRefPubMed Dahl JB, Rosenberg J, Dirkes WE, Mogensen T, Kehlet H (1990) Prevention of postoperative pain by balanced analgesia. Br J Anaesth 64:518–520CrossRefPubMed
7.
go back to reference Ure BM, Troidl H, Spangenberger W, Dietrich A, Lefering R, Neugebauer E (1994) Pain after laparoscopic cholecystectomy. Intensity and localization of pain and analysis of predictors in preoperative symptoms and intraoperative events. Surg Endosc 8:90–96CrossRefPubMed Ure BM, Troidl H, Spangenberger W, Dietrich A, Lefering R, Neugebauer E (1994) Pain after laparoscopic cholecystectomy. Intensity and localization of pain and analysis of predictors in preoperative symptoms and intraoperative events. Surg Endosc 8:90–96CrossRefPubMed
8.
go back to reference Khaitan L, Apelgren K, Hunter J, Traverso LW (2003) A report on the Society of American Gastrointestinal Endoscopic Surgeons (SAGES) Outcomes Initiative: what have we learned and what is its potential? Surg Endosc 17:365–370CrossRefPubMed Khaitan L, Apelgren K, Hunter J, Traverso LW (2003) A report on the Society of American Gastrointestinal Endoscopic Surgeons (SAGES) Outcomes Initiative: what have we learned and what is its potential? Surg Endosc 17:365–370CrossRefPubMed
9.
go back to reference Michaloliakou C, Chung F, Sharma S (1996) Preoperative multimodal analgesia facilitates recovery after ambulatory laparoscopic cholecystectomy. Anesth Analg 82:44–51PubMed Michaloliakou C, Chung F, Sharma S (1996) Preoperative multimodal analgesia facilitates recovery after ambulatory laparoscopic cholecystectomy. Anesth Analg 82:44–51PubMed
10.
go back to reference Qin X, Huo Y, Langman CB, Hou F, Chen Y, Matossian D, Xu X, Wang X (2011) Folic acid therapy and cardiovascular disease in ESRD or advanced chronic kidney disease: a meta-analysis. Clin J Am Soc Nephrol 6:482–488CrossRefPubMedPubMedCentral Qin X, Huo Y, Langman CB, Hou F, Chen Y, Matossian D, Xu X, Wang X (2011) Folic acid therapy and cardiovascular disease in ESRD or advanced chronic kidney disease: a meta-analysis. Clin J Am Soc Nephrol 6:482–488CrossRefPubMedPubMedCentral
11.
12.
go back to reference Cheng PGB, Lim MJ, Onsiong MK, Chiu KYW, Chan MK, Li KWM, Tang CN (2004) Celecoxib premedication in post-operative analgesia for laparoscopic cholecystectomy. Acute Pain 6:23–28CrossRef Cheng PGB, Lim MJ, Onsiong MK, Chiu KYW, Chan MK, Li KWM, Tang CN (2004) Celecoxib premedication in post-operative analgesia for laparoscopic cholecystectomy. Acute Pain 6:23–28CrossRef
13.
go back to reference Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral
14.
go back to reference Bisgaard T, Klarskov B, Kristiansen VB, Callesen T, Schulze S, Kehlet H, Rosenberg J (1999) Multi-regional local anesthetic infiltration during laparoscopic cholecystectomy in patients receiving prophylactic multi-modal analgesia: a randomized, double-blinded, placebo-controlled study. Anesth Analg 89:1017–1024PubMed Bisgaard T, Klarskov B, Kristiansen VB, Callesen T, Schulze S, Kehlet H, Rosenberg J (1999) Multi-regional local anesthetic infiltration during laparoscopic cholecystectomy in patients receiving prophylactic multi-modal analgesia: a randomized, double-blinded, placebo-controlled study. Anesth Analg 89:1017–1024PubMed
15.
go back to reference Joris J, Thiry E, Paris P, Weerts J, Lamy M (1995) Pain after laparoscopic cholecystectomy: characteristics and effect of intraperitoneal bupivacaine. Anesth Analg 81:379–384PubMed Joris J, Thiry E, Paris P, Weerts J, Lamy M (1995) Pain after laparoscopic cholecystectomy: characteristics and effect of intraperitoneal bupivacaine. Anesth Analg 81:379–384PubMed
16.
go back to reference Wallace DH, Serpell MG, Baxter JN, O’Dwyer PJ (1997) Randomized trial of different insufflation pressures for laparoscopic cholecystectomy. Br J Surg 84:455–458CrossRefPubMed Wallace DH, Serpell MG, Baxter JN, O’Dwyer PJ (1997) Randomized trial of different insufflation pressures for laparoscopic cholecystectomy. Br J Surg 84:455–458CrossRefPubMed
17.
go back to reference Joshi GP, Viscusi ER, Gan TJ, Minkowitz H, Cippolle M, Schuller R, Cheung RY, Fort JG (2004) Effective treatment of laparoscopic cholecystectomy pain with intravenous followed by oral COX-2 specific inhibitor. Anesth Analg 98:336–342CrossRefPubMed Joshi GP, Viscusi ER, Gan TJ, Minkowitz H, Cippolle M, Schuller R, Cheung RY, Fort JG (2004) Effective treatment of laparoscopic cholecystectomy pain with intravenous followed by oral COX-2 specific inhibitor. Anesth Analg 98:336–342CrossRefPubMed
18.
go back to reference Cochrane DJ, Jarvis B, Keating GM (2002) Etoricoxib. Drugs 62:2637–2651 (discussion 2652–2653) CrossRefPubMed Cochrane DJ, Jarvis B, Keating GM (2002) Etoricoxib. Drugs 62:2637–2651 (discussion 2652–2653) CrossRefPubMed
19.
go back to reference Agrawal NG, Porras AG, Matthews CZ, Woolf EJ, Miller JL, Mukhopadhyay S, Neu DC, Gottesdiener KM (2001) Dose proportionality of oral etoricoxib, a highly selective cyclooxygenase-2 inhibitor, in healthy volunteers. J Clin Pharmacol 41:1106–1110CrossRefPubMed Agrawal NG, Porras AG, Matthews CZ, Woolf EJ, Miller JL, Mukhopadhyay S, Neu DC, Gottesdiener KM (2001) Dose proportionality of oral etoricoxib, a highly selective cyclooxygenase-2 inhibitor, in healthy volunteers. J Clin Pharmacol 41:1106–1110CrossRefPubMed
20.
go back to reference Dallob A, Hawkey CJ, Greenberg H, Wight N, De Schepper P, Waldman S, Wong P, DeTora L, Gertz B, Agrawal N, Wagner J, Gottesdiener K (2003) Characterization of etoricoxib, a novel, selective COX-2 inhibitor. J Clin Pharmacol 43:573–585CrossRefPubMed Dallob A, Hawkey CJ, Greenberg H, Wight N, De Schepper P, Waldman S, Wong P, DeTora L, Gertz B, Agrawal N, Wagner J, Gottesdiener K (2003) Characterization of etoricoxib, a novel, selective COX-2 inhibitor. J Clin Pharmacol 43:573–585CrossRefPubMed
21.
go back to reference Hunt RH, Harper S, Watson DJ, Yu C, Quan H, Lee M, Evans JK, Oxenius B (2003) The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events. Am J Gastroenterol 98:1725–1733CrossRefPubMed Hunt RH, Harper S, Watson DJ, Yu C, Quan H, Lee M, Evans JK, Oxenius B (2003) The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events. Am J Gastroenterol 98:1725–1733CrossRefPubMed
Metadata
Title
Combination of etoricoxib and low-pressure pneumoperitoneum versus standard treatment for the management of pain after laparoscopic cholecystectomy: a randomized controlled trial
Authors
Wasana Ko-iam
Sahataya Paiboonworachat
Paisal Pongchairerks
Sunhawit Junrungsee
Trichak Sandhu
Publication date
01-11-2016
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 11/2016
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-016-4810-4

Other articles of this Issue 11/2016

Surgical Endoscopy 11/2016 Go to the issue